Superoxide scavenging activity of pirfenidone-iron complex

Biochemical and Biophysical Research Communications

Volumn 372, Issue 1, 2008, Pages 19-23

  Mitani, Yoshihiro ^a   Sato, Keizo ^a   Muramoto, Yosuke ^a   Karakawa, Tomohiro ^a   Kitamado, Masataka ^a   Iwanaga, Tatsuya ^b   Nabeshima, Tetsuji ^c   Maruyama, Kumiko ^a   Nakagawa, Kazuko ^a   Ishida, Kazuhiko ^b   Sasamoto, Kazumi ^c  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Dojindo Laboratories   (Japan)

^c Dojin Glocal Corporation   (Japan)

Author keywords

2,2 Dimethyl 3,4 dihydro 2H pyrrole N oxide (DMPO); Electron spin resonance; Free radical; Neutrophil; Xanthine oxidase

Indexed keywords

ALCOHOL; ANTIFIBROTIC AGENT; CYTOCHROME C; FERROUS CHLORIDE; HYPOXANTHINE; IRON COMPLEX; LUMINOL; PHORBOL ESTER; PIRFENIDONE; SCAVENGER; SUPEROXIDE; WATER; XANTHINE OXIDASE;

ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DISTILLATION; DRUG EFFECT; DRUG STABILITY; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL; REDUCTION;

CELL LINE; FREE RADICAL SCAVENGERS; HUMANS; IRON; NEUTROPHILS; PULMONARY FIBROSIS; PYRIDONES; SUPEROXIDES;

EID: 44649083783     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.04.093     Document Type: Article

References (24)

1. Iyer S.N., Wild J.S., Schiedt M.J., Hyde D.M., Margolin S.B., and Giri S.N. Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters. J. Lab. Clin. Med. 125 (1995) 779-785
2. Kehrer J.P., and Margolin S.B. Pirfenidone diminishes cyclophosphamide-induced lung fibrosis in mice. Toxicol. Lett. 90 (1997) 125-132
3. Shimizu T., Kuroda T., Hata S., Fukagawa M., Margolin S.B., and Kurokawa K. Pirfenidone improves renal function and fibrosis in the post-obstructed kidney. Kidney Int. 54 (1998) 99-109
4. Miric G., Dallemagne C., Endre Z., Margolin S., Taylor S.M., and Brown L. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br. J. Pharmacol. 133 (2001) 687-694
5. Garcia L., Hernandez I., Sandoval A., Salazar A., Garcia J., Vera J., Grijalva G., Muriel P., Margolin S., and Armendariz-Borunda J. Pirfenidone effectively reverses experimental liver fibrosis. J. Hepatol. 37 (2002) 797-805
6. Azuma A., Nukiwa T., Tsuboi E., Suga M., Abe S., Nakata K., Taguchi Y., Nagai S., Itoh H., Ohi M., Sato A., and Kudoh S. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 171 (2005) 1040-1047
7. Raghu G., Johnson W.C., Lockhart D., and Mageto Y. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study. Am. J. Respir. Crit. Care Med. 159 (1999) 1061-1069
8. Oku H., Nakazato H., Horikawa T., Tsuruta Y., and Suzuki R. Pirfenidone suppresses tumor necrosis factor-alpha, enhances interleukin-10 and protects mice from endotoxic shock. Eur. J. Pharmacol. 446 (2002) 167-176
9. Card J.W., Racz W.J., Brien J.F., Margolin S.B., and Massey T.E. Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity. Toxicol. Sci. 75 (2003) 169-180
10. Muranaka H., Suga M., Sato K., Nakagawa K., Akaike T., Okamoto T., Maeda H., and Ando M. Superoxide scavenging activity of erythromycin-iron complex. Biochem. Biophys. Res. Commun. 232 (1997) 183-187
11. Itami C., Matsunaga H., Sawada T., Sakurai H., and Kimura Y. Superoxide dismutase mimetic activities of metal complexes of l-2(2-pyridyl)-1-pyrroline-5-carboxylic acid (pyrimine). Biochem. Biophys. Res. Commun. 197 (1993) 536-541
12. Venaille T.J., Misso N.L., Phillips M.J., Robinson B.W., and Thompson P.J. Effects of different density gradient separation techniques on neutrophil function. Scand J. Clin. Lab. Invest. 54 (1994) 385-391
13. Shihab F.S., Bennett W.M., Yi H., and Andoh T.F. Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity. Am. J. Transplant 2 (2002) 111-119
14. Kaneko M., Inoue H., Nakazawa R., Azuma N., Suzuki M., Yamauchi S., Margolin S.B., Tsubota K., and Saito I. Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts. Clin. Exp. Immunol. 113 (1998) 72-76
15. Iyer S.N., Gurujeyalakshmi G., and Giri S.N. Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J. Pharmacol. Exp. Ther. 291 (1999) 367-373
16. Mei S., Yao W., Zhu Y., and Zhao J. Protection of pirfenidone against an early phase of oleic acid-induced acute lung injury in rats. J. Pharmacol. Exp. Ther. 313 (2005) 379-388
17. Misra H.P., and Rabideau C. Pirfenidone inhibits NADPH-dependent microsomal lipid peroxidation and scavenges hydroxyl radicals. Mol. Cell. Biochem. 204 (2000) 119-126
18. Tampo Y., Tsukamoto M., and Yonaha M. Superoxide production from paraquat evoked by exogenous NADPH in pulmonary endothelial cells. Free Radic. Biol. Med. 27 (1999) 588-595
19. Zhang H., Slutsky A.S., and Vincent J.L. Oxygen free radicals in ARDS, septic shock and organ dysfunction. Intensive Care Med. 26 (2000) 474-476
20. Yang C., Moriuchi H., Takase J., Ishitsuka Y., Irikura M., and Irie T. Oxidative stress in early stage of acute lung injury induced with oleic acid in guinea pigs. Biol. Pharm. Bull. 26 (2003) 424-428
21. Iyer S.N., Margolin S.B., Hyde D.M., and Giri S.N. Lung fibrosis is ameliorated by pirfenidone fed in diet after the second dose in a three-dose bleomycin-hamster model. Exp. Lung Res. 24 (1998) 119-132
22. Rabbani Z.N., Batinic-Haberle I., Anscher M.S., Huang J., Day B.J., Alexander E., Dewhirst M.W., and Vujaskovic Z. Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury. Int. J. Radiat. Oncol. Biol. Phys. 67 (2007) 573-580
23. Vujaskovic Z., Batinic-Haberle I., Rabbani Z.N., Feng Q.F., Kang S.K., Spasojevic I., Samulski T.V., Fridovich I., Dewhirst M.W., and Anscher M.S. A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury. Free Radic. Biol. Med. 33 (2002) 857-863
24. Hay J., Shahzeidi S., and Laurent G. Mechanisms of bleomycin-induced lung damage. Arch. Toxicol. 65 (1991) 81-94